2Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda system:terminology for reporting result of cervical cytology .JAMA, 2002,287(16):2114-2119
3Gravitt PE,Peyton CL,Alessi TQ,et al.Improved amplification of genital human papillomavirus .J Clin Microbiol,2000,38(1):357-361
4Kaufman RH.Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion:diagnostic criteria and management.Am J Obstet Gynecol,1996,175(4pt2):1120-1126
5Propst T, Propst A,Herold M,et al.High levels of interleukin 6 and its secondary mediators in spontaneous bacterial peritonitis.Gastroenterology,2003,105(1):310-318
6Hatch KD,Schneider A,Abdel-Nour M,et al.An evaluation of human papillomavirus testing for intermediate and high-risk types as triage before colposcopy .Am J Obstet Gynecol ,1995,172(4pt1):1150-1155
7Wright TC Jr , Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA, 2002,287 (16):2120-2129
2Park JY,Lee SM,Yoo CW,et al.Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia(CIN)Ⅲ and microinvasive cervical cancer[J].Gynecol Oncol,2007 107(1):39-44.
3Charoenkwan K,Srisomboon J,Siriaunkgul S,et al."See and Treat"approach for high grade squamous intraepithelial lesion on cervical cytology[J].J Med Assoc Thai,2004,87(8):865-868.
4Jeong NH,Lee NW,Kim HJ,et al.High-risk humanpa pillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia[J].Obstet Gynecol Res,2009,35(4):706-711.
5Baloglu A,Uysal D,Bezircioglu I,et al.Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions[J].Arch Gynecol Obstet,2010,282(1):69-73.
6Castle PE,Cox JT,Jeronimo J,et al.An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LISL Triage Study (ALTS)[J].Obstet Gynecol,2008,111(4):847-856.
7Bandyopadhyay S,Austin RM,Dabbs D,et al.Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaon test results[J].Arch Pathol Lab Med,2008,132(12):1874-1881.
8Sankaranarayanan R,Nene BM,Shastri SS,et al.HPV screening for cervical cancer in rural India[J].N Engl J Med,2009,360(14):1385-1394.
9Vinokurova S,Wentzensen N,Kraus I,et al.Type-dependment integrainon frequency of human papilloma virus genomes in cervical lesions[J].Cancer Res,2008,68(1):307-313.
